Clover Health [CLOV] vs UnitedHealth [UNH] Detailed Stock Comparison
Clover Health
NASDAQ
Loading...
UnitedHealth
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Clover Health wins in 6 metrics, UnitedHealth wins in 12 metrics, with 0 ties. UnitedHealth appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Clover Health | UnitedHealth | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -31.50 | 13.35 | Clover Health |
| Price-to-Book Ratio | 3.87 | 2.95 | UnitedHealth |
| Debt-to-Equity Ratio | 0.00 | 75.58 | Clover Health |
| PEG Ratio | 0.10 | -0.75 | UnitedHealth |
| EV/EBITDA | -28.18 | 10.03 | Clover Health |
| Profit Margin (TTM) | -2.68% | 5.04% | UnitedHealth |
| Operating Margin (TTM) | -2.21% | 4.61% | UnitedHealth |
| EBITDA Margin (TTM) | N/A | 4.61% | N/A |
| Return on Equity | -12.59% | 21.65% | UnitedHealth |
| Return on Assets (TTM) | -4.26% | 6.46% | UnitedHealth |
| Free Cash Flow (TTM) | $33.29M | $20.71B | UnitedHealth |
| Dividend Yield | N/A | 2.05% | N/A |
| 1-Year Return | -21.86% | -48.10% | Clover Health |
| Price-to-Sales Ratio (TTM) | 0.83 | 0.66 | UnitedHealth |
| Enterprise Value | $1.16B | $336.62B | UnitedHealth |
| EV/Revenue Ratio | 0.72 | 0.80 | Clover Health |
| Gross Profit Margin (TTM) | 20.86% | 17.93% | Clover Health |
| Revenue per Share (TTM) | $3 | $462 | UnitedHealth |
| Earnings per Share (Diluted) | $-0.08 | $23.11 | UnitedHealth |
| Beta (Stock Volatility) | 1.92 | 0.44 | UnitedHealth |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Clover Health vs UnitedHealth Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Clover Health | 2.76% | 1.56% | -16.08% | -25.85% | -40.68% | -16.61% |
| UnitedHealth | 1.17% | 11.74% | 7.52% | 0.12% | -34.96% | -39.87% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Clover Health | -21.86% | -8.42% | -74.98% | -74.41% | -74.41% | -74.41% |
| UnitedHealth | -48.10% | -42.68% | -3.51% | 158.65% | 837.13% | 501.29% |
Performance & Financial Health Analysis: Clover Health vs UnitedHealth
| Metric | CLOV | UNH |
|---|---|---|
| Market Information | ||
| Market Cap | $1.34B | $279.39B |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 11,461,635 | 23,445,120 |
| 90 Day Avg. Volume | 9,929,865 | 19,607,197 |
| Last Close | $2.61 | $303.35 |
| 52 Week Range | $2.12 - $4.87 | $234.60 - $630.73 |
| % from 52W High | -46.41% | -51.90% |
| All-Time High | $28.85 (Jun 07, 2021) | $630.73 (Nov 11, 2024) |
| % from All-Time High | -90.95% | -51.90% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.13% |
| Quarterly Earnings Growth | 0.34% | -0.19% |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | 0.05% |
| Operating Margin (TTM) | -0.02% | 0.05% |
| Return on Equity (TTM) | -0.13% | 0.22% |
| Debt to Equity (MRQ) | 0.00 | 75.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.67 | $104.67 |
| Cash per Share (MRQ) | $0.39 | $35.36 |
| Operating Cash Flow (TTM) | $-46,732,000 | $28.96B |
| Levered Free Cash Flow (TTM) | $83.15M | $27.21B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.05% |
| Last 12-Month Dividend | N/A | $6.30 |
Valuation & Enterprise Metrics Analysis: Clover Health vs UnitedHealth
| Metric | CLOV | UNH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -31.50 | 13.35 |
| Forward P/E | -18.64 | 10.32 |
| PEG Ratio | 0.10 | -0.75 |
| Price to Sales (TTM) | 0.83 | 0.66 |
| Price to Book (MRQ) | 3.87 | 2.95 |
| Market Capitalization | ||
| Market Capitalization | $1.34B | $279.39B |
| Enterprise Value | $1.16B | $336.62B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.72 | 0.80 |
| Enterprise to EBITDA | -28.18 | 10.03 |
| Risk & Other Metrics | ||
| Beta | 1.92 | 0.44 |
| Book Value per Share (MRQ) | $0.67 | $104.67 |
Financial Statements Comparison: Clover Health vs UnitedHealth
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CLOV | UNH |
|---|---|---|
| Revenue/Sales | $462.33M | $111.62B |
| Cost of Goods Sold | $353.44M | $91.60B |
| Gross Profit | $108.89M | $20.01B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-1.27M | $5.15B |
| EBITDA | $-808,000 | $6.23B |
| Pre-Tax Income | $-1.27M | $4.08B |
| Income Tax | N/A | $510.00M |
| Net Income (Profit) | $-1.27M | $3.57B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CLOV | UNH |
|---|---|---|
| Cash & Equivalents | $155.44M | $30.72B |
| Total Current Assets | $331.41M | $96.29B |
| Total Current Liabilities | $215.65M | $113.47B |
| Long-Term Debt | N/A | $71.29B |
| Total Shareholders Equity | $336.08M | $105.17B |
| Retained Earnings | $-2.20B | $97.93B |
| Property, Plant & Equipment | $5.03M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CLOV | UNH |
|---|---|---|
| Operating Cash Flow | $-24.27M | $2.45B |
| Capital Expenditures | $-185,000 | $-898.00M |
| Free Cash Flow | $-16.48M | $4.56B |
| Debt Repayment | N/A | $0 |
| Common Stock Repurchase | $-31.96M | $-3.00B |
Short Interest & Institutional Ownership Analysis
| Metric | CLOV | UNH |
|---|---|---|
| Shares Short | 41.04M | 15.23M |
| Short Ratio | 4.25 | 0.98 |
| Short % of Float | 0.10% | 0.02% |
| Average Daily Volume (10 Day) | 11,461,635 | 23,445,120 |
| Average Daily Volume (90 Day) | 9,929,865 | 19,607,197 |
| Shares Outstanding | 503.53M | 915.00M |
| Float Shares | 400.28M | 897.82M |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 0.35% | 0.87% |
Dividend Analysis & Yield Comparison: Clover Health vs UnitedHealth
| Metric | CLOV | UNH |
|---|---|---|
| Last 12-Month Dividend | N/A | $6.30 |
| Last 12-Month Dividend Yield | N/A | 2.05% |
| 3-Year Avg Annual Dividend | N/A | $6.33 |
| 3-Year Avg Dividend Yield | N/A | 0.38% |
| 3-Year Total Dividends | N/A | $18.99 |
| Ex-Dividend Date | N/A | Mar 10, 2025 |